Global betaine market is projected to surpass around USD 3.2 Billion by 2025 and is anticipated to develop at CAGR of nearly 5.8% from 2019 to 2025.
The global Betaine market is estimated to garner revenue of nearly 3.2(USD Billion) by 2025 and is projected to grow at a CAGR of about 5.8% during the timespan from 2019 to 2025. The report offers valuation and analysis of the Betaine market on a global as well as regional level. The study offers a comprehensive assessment of the industry competition, limitations, revenue estimates, avenues, current & emerging trends, and industry-validated market data. The report offers historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on value (USD Billion).
Betaine, which is also referred to as trimethylglycine, is found extensively in microbes, animals, and plants and performs vital physiological functions in these living organisms. According to the NCBI, Betaine has the ability to prevent chronic ailments and its intake in the diet is likely to contribute towards the overall health growth in the foreseeable future. Most of the research studies have stated that populations across the globe consume less of Betaine. It has also suggested a few of the nutritional strategies to increase the use of Betaine in the diets of the people.
Key Growth Drivers
As per NCBI, studies with empirical evidence have demonstrated that Betaine acts as an anti-inflammatory product in various ailments. Moreover, Betaine improves metabolism activity of sulfur amino acid against oxidative strain and obstructs nuclear factors such as κB activity and inflammasome initiation of NLRP3. In addition to this, the product helps in regulating energy metabolism along with lessening the stress of endoplasmic reticulum & apoptosis. All these factors are anticipated to steer the growth of the Betaine market over the forecast timeline.
|Historic Years||2018 - 2022|
|Forecast Years||2023 - 2030|
|Segments Covered||By Product Type, By Application, and By End Use|
|Forecast Units||Value (USD Billion), and Volume (Units)|
|Quantitative Units||Revenue in USD million/billion and CAGR from 2023 to 2030|
|Regions Covered||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World|
|Countries Covered||U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others|
|Number of Companies Covered||10 companies with scope for including additional 15 companies upon request|
|Report Coverage||Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.|
|Customization Scope||Avail customized purchase options to meet your exact research needs.|
Apparently, Betaine has beneficial impacts on myriad human ailments like obesity, cancer, Alzheimer’s ailment, and diabetes. This will further spur the growth of the Betaine industry over the forecast period. Furthermore, it also helps in maintaining water homeostasis playing a key part during heat stress. Additionally, the product is capable of counteracting a high level of homocysteine in plasma and increase plasma levels of S-adenosyl-methionine.
North American Market To Accrue Huge Gains Over Forecast Period
The growth of the regional market over the forecast timeline is due to the recognition of the Betaine as GRAS or Generally Recognized as Safe ingredient in the countries like the U.S. Furthermore, the product finds lucrative applications across the personal care and pharmaceutical industries across the region.
Furthermore, Betaine has also received approval from the European Commission in 2012. For the record, European Union Regulatory Authority allowed the declaration of healthy claim on diets comprising nearly 500 mg of Betaine per food serving, demonstrating that good effects on health can be availed if 1500 mg if Betaine is administered in the body per day. According to the medical statement made by the EU, the product contributes to normal homocysteine metabolism. All these aforementioned aspects will prompt the use of the product on the continent and will drive the regional market growth over the forecast timespan.
Key players profiled in the Betaine industry include Sunwin Chemicals, Associated British Foods Plc, Lubrizol, Amino GmbH, BASF SE, DuPont, Stepan Company, Solvay, American Crystal Sugar Company, Nutreco N.V., and KAO Corp.